Markets US Stocks Health Technology Biotechnology BCRX Financials

BioCryst Pharmaceuticals, Inc

BCRX

See more on advanced chart See more on advanced chart

No trades

See more on advanced chart See more on advanced chart

Overview News Ideas

Financials

BCRX financial statements

An in-depth look to BioCryst Pharmaceuticals, Inc operating, investing, and financing activities

BCRX free cash flow for Q1 22 is -78.21M USD. For 2021, BCRX free cash flow was -144.54M USD and operating cash flow was -142.16M USD.

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—